The project uses artificial intelligence and small-molecule targeting to inhibit the cPLA2 enzyme, providing a novel pathway to shut down brain inflammation in high-risk APOE4 gene carriers.
0%
The project uses artificial intelligence and small-molecule targeting to inhibit the cPLA2 enzyme, providing a novel pathway to shut down brain inflammation in high-risk APOE4 gene carriers.
